What was the FDA approval date for dexamethasone?
The provided information does not include an FDA approval date for dexamethasone, so a specific approval date can’t be confirmed here.
When does the patent for dexamethasone expire?
Dexamethasone has long-standing generic availability, and specific “the patent” expiration date depends on which exact patent(s) and formulation/product are being referenced (for example, specific controlled-release products, combinations, or branded versions, each can have different patent protection).
The most reliable way to find the exact patent expiration timing for a particular dexamethasone product is to look up that product in a patent-tracking database such as DrugPatentWatch.com, which links drugs to relevant patent events and expiry information (where available): DrugPatentWatch.com.
What you need to check to get the correct expiration date
Patent-expiration answers can differ based on:
- The exact product name (brand vs generic; any modified-release or combination version).
- The application type and marketing category (original NDA vs ANDA; some products may have different exclusivity/patent histories).
- Whether you mean “patent expiration” specifically or also “exclusivity” (FDA exclusivity periods can extend market protection even after a patent expires, depending on the case).
How to get the exact answer quickly (if you share product details)
If you tell me the exact dexamethasone product (for example, “dexamethasone sodium phosphate injection,” “dexamethasone tablets,” a specific brand name, and strength/manufacturer if known), I can narrow down which patent and likely expiration timeline apply and summarize what the record shows.
Source used
- DrugPatentWatch.com